Update on Regulatory Withdrawals of Drug Pricing Rules, by Bridget C.E. Dooling & Rachel E. Sachs
This week, the U.S. District Court for the Southern District of Indiana issued a preliminary injunction in Eli Lilly & Co. v. Cochran to prevent the U.S. Department of Health & Human Services (HHS) from implementing an alternative dispute resolution rule that applied to the 340B drug pricing program, on the grounds that the agency […]